EVE — Eve Health Income Statement
0.000.00%
Last trade - 00:00- AU$6.40m
- AU$5.59m
- AU$1.73m
Annual income statement for Eve Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.8 | 2.01 | 2.33 | 2.13 | 1.73 |
| Cost of Revenue | |||||
| Gross Profit | 1.31 | 0.745 | 0.828 | 0.877 | 0.824 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.28 | 7.03 | 4.72 | 3.71 | 3.19 |
| Operating Profit | -3.48 | -5.02 | -2.39 | -1.58 | -1.45 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.63 | -5.12 | -2.35 | -1.55 | -1.45 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.63 | -5.12 | -2.35 | -1.55 | -1.45 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.63 | -5.37 | -4.04 | -1.9 | -1.58 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.63 | -5.37 | -4.04 | -1.9 | -1.58 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.034 | -0.042 | -0.018 | -0.012 | -0.011 |